Precision therapies take aim at non-Hodgkin’s lymphoma
Elie Dolgin • November 14, 2018
The dramatic success of ibrutinib has created a more hopeful reality for people with lymphoma, as targeted therapies fill the pipeline.
Continue reading here.
Animals that researchers call “supersucklers” come back for their mother’s milk even after they can hunt, mate and fend for themselves.
Destroying dysfunctional tissue could reset metabolism.